Ignite Creation Date:
2025-12-24 @ 11:49 AM
Ignite Modification Date:
2025-12-29 @ 5:05 PM
Study NCT ID:
NCT01485861
Status:
COMPLETED
Last Update Posted:
2023-09-14
First Post:
2011-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2015-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-02
First Submit QC Date:
None
Study First Post Date:
2011-12-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-08-17
Results First Submit QC Date:
None
Results First Post Date:
2023-09-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-17
Last Update Post Date:
2023-09-14
Last Update Post Date Type:
ACTUAL